(Q94571342)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

title

Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

evasion of host immune response

16 May 2020

main subject

1 reference

1 reference

diffuse large B-cell lymphoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

21

Eivind Hovig

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

24

Harald Holte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Ole Christian Lingjærde

7

object named as

Ole Christian Lingjærde

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

16

Ola Myklebost

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

author name string

Jillian F Wise

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Chloé B Steen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Daniel Vodák

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Gunhild Trøen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Bjarne Johannessen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Vera Hilden

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Yngvild Nuvin Blaker

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Baoyan Bai

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Lars Birger Aasheim

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Annika Pasanen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Susanne Lorenz

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Anita Sveen

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Ragnhild A Lothe

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Sirpa Leppä

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Leonardo A Meza-Zepeda

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Klaus Beiske

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Michael S Lawrence

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

June Helen Myklebust

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Erlend B Smeland

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

publication date

1 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

page(s)

1859-1866

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure

16 May 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Open Targets Platform: new developments and updates two years on

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

CADD: predicting the deleteriousness of variants throughout the human genome

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Aggressive lymphoma 2016: revision of the WHO classification

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Visualizing tumor evolution with the fishplot package for R

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

IntOGen-mutations identifies cancer drivers across tumor types.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Mutational heterogeneity in cancer and the search for new cancer-associated genes

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Diffuse large B-cell lymphoma

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Genetic heterogeneity of diffuse large B-cell lymphoma

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Analysis of the coding genome of diffuse large B-cell lymphoma

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Allele-specific copy number analysis of tumors

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Mol

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy

11 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7218413

10.1182/BLOODADVANCES.2019001325

11 February 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32374878%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

1 reference